Translational findings from cardiovascular stem cell research

Trends in Cardiovascular Medicine

Volumn 22, Issue 1, 2012, Pages 1-6

  Mazhari, Ramesh ^a   Hare, Joshua M ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL REGENERATION; CONGESTIVE HEART FAILURE; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; TRANSLATIONAL RESEARCH;

CARDIOVASCULAR DISEASES; HEART; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84865586758     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.05.017     Document Type: Review

References (51)

1. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med 2007, 167:989-997.
2. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005, 102:11474-11479.
3. Anversa P., Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 2002, 415:240-243.
4. Assmus B., Rolf A., Erbs S., et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Failure 2010, 3:89-96.
5. Bolli R., Chugh A.R., D'Amario D., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 2011, 378:1847-1857.
6. Burdon T.J., Paul A., Noiseux N., et al. Bone marrow stem cell derived paracrine factors for regenerative medicine: Current perspectives and therapeutic potential. Bone Marrow Res 2011, 2011:207326.
7. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004, 94:92-95.
8. Fernandes S., van Rijen H.V., Forest V., et al. Cardiac cell therapy: Overexpression of connexin 43 in skeletal myoblasts and prevention of ventricular arrhythmias. J Cell Mol Med 2009, 13:3703-3712.
9. Ferreira-Martins J., Ogórek B., Cappetta D., et al. Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ Res 2012, 110:701-715.
10. Halkos M.E., Zhao Z.Q., Kerendi F., et al. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol 2008, 103:525-536.
11. Hare J.M., Traverse J.H., Henry T.D., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009, 54:2277-2286.
12. Hatzistergos K.E., Quevedo H., Oskouei B.N., et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010, 107:913-922.
13. Hierlihy A.M., Seale P., Lobe C.G., et al. The postnatal heart contains a myocardial stem cell population. FEBS Lett 2002, 530:239-243.
14. Johnston P.V., Sasano T., Mills K., et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120:1075-1083.
15. Koh G.Y., Klug M.G., Soonpaa M.H., Field L.J. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 1993, 92:1548-1554.
16. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
17. Linke A., Müller P., Nurzynska D., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 2005, 102:8966-8971.
18. Makkar R.R., Smith R.R., Cheng K., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
19. Menasché P. Skeletal myoblasts for cardiac repair: Act II?. J Am Coll Cardiol 2008, 52:1881-1883.
20. Menasché P. Cardiac cell therapy: Lessons from clinical trials. J Mol Cell Cardiol 2011, 50:258-265.
21. Menasché P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
22. Menasché P., Hagege A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet 2001, 357:279-280.
23. Messina E., De Angelis L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004, 95:911-921.
24. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
25. Mohsin S., Siddiqi S., Collins B., Sussman M.A. Empowering adult stem cells for myocardial regeneration. Circ Res 2011, 109:1415-1428.
26. Narazaki G., Uosaki H., Teranishi M., et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008, 118:498-506.
27. Nelson T.J., Martinez-Fernandez A., Yamada S., et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009, 120:408-416.
28. Oh H., Bradfute S.B., Gallardo T.D., et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003, 100:12313-12318.
29. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001, 98:10344-10349.
30. Perin E.C., Silva G.V., Assad J.A., et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 2008, 44:486-495.
31. + cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005, 97:52-61.
32. Qi C.M., Ma G.S., Liu N.F., et al. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model. Chinese Med J 2008, 121:544-550.
33. Quevedo H.C., Hatzistergos K.E., Oskouei B.N., et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 2009, 106:14022-14027.
34. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012, 125:e2-e220.
35. Rota M., Boni A., Urbanek K., et al. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res 2005, 97:1332-1341.
36. Rota M., Padin-Iruegas M.E., Misao Y., et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008, 103:107-116.
37. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355:1210-1221.
38. Sherman W., Martens T.P., Viles-Gonzalez J.F., Siminiak T. Catheter-based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med 2006, 3:S57-S64.
39. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
40. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
41. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 1998, 4:929-933.
42. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
43. Trachtenberg B., Velazquez D.L., Williams A.R., et al. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 2011, 161:487-493.
44. Traverse J.H., Henry T.D., Ellis S.G., et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial. JAMA 2011, 306:2110-2119.
45. Traverse J.H., Henry T.D., Vaughan D.E., et al. Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J 2009, 158:356-363.
46. Urbanek K., Cesselli D., Rota M., et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A 2006, 103:9226-9231.
47. Wang X., Jameel M.N., Li Q., et al. Stem cells for myocardial repair with use of a transarterial catheter. Circulation 2009, 120:S238-S246.
48. Williams A.R., Hare J.M. Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 2011, 109:923-940.
49. Williams A.R., Trachtenberg B., Velazquez D.L., et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: Functional recovery and reverse remodeling. Circ Res 2011, 108:792-796.
50. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
51. Yoshida Y., Yamanaka S. iPS cells: A source of cardiac regeneration. J Mol Cell Cardiol 2011, 50:327-332.